| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Mar 12, 2026 |
Ardelyx Inc
ARDX
|
BUY |
$17.00
Est. +200%
|
$5.66 | $7.43 |
Pending
|
$5.27
-6.9%
|
| Mar 10, 2026 |
Cytokinetics Inc
CYTK
|
BUY |
$84.00
Est. +32%
|
$63.55 | $88.31 |
Target Met
|
$86.49
+36.1%
|
| Mar 10, 2026 |
ARS Pharmaceuticals Inc
SPRY
|
BUY |
$26.00
Est. +180%
|
$9.28 | $10.87 |
Pending
|
$8.56
-7.8%
|
| Mar 06, 2026 |
CorMedix Inc
CRMD
|
BUY |
$13.00
Est. +101%
|
$6.46 | $9.09 |
Pending
|
$8.75
+35.4%
|
| Feb 26, 2026 |
Vir Biotechnology Inc
VIR
|
BUY |
$20.00
Est. +114%
|
$9.33 | $11.66 |
Pending
|
$10.04
+7.6%
|
| Jan 06, 2026 |
NewAmsterdam Pharma Company NV
NAMS
|
BUY |
$55.00
Est. +64%
|
$33.48 | $42.21 |
Pending
|
$34.83
+4.0%
|
| Dec 22, 2025 |
Cytokinetics Inc
CYTK
|
BUY |
$83.00
Est. +21%
|
$68.46 | $88.31 |
Target Met
|
$86.49
+26.3%
|
| Nov 19, 2025 |
Trevi Therapeutics Inc
TRVI
|
BUY |
$16.00
Est. +41%
|
$11.31 | $19.26 |
Target Met
|
$17.93
+58.5%
|
| Oct 17, 2025 |
iBio Inc
IBIO
|
BUY |
$2.00
Est. +135%
|
$0.85 | $3.82 |
Target Met
|
$1.68
+97.6%
|
| Nov 20, 2024 |
NewAmsterdam Pharma Company NV
NAMS
|
BUY |
$45.00
Est. +125%
|
$20.01 | $41.47 |
Miss
|
$34.83
+74.1%
|
| Oct 18, 2024 |
Lexicon Pharmaceuticals Inc
LXRX
|
BUY |
$6.00
Est. +199%
|
$2.01 | $2.18 |
Miss
|
$2.32
+15.4%
|
| Mar 05, 2024 |
ARS Pharmaceuticals Inc
SPRY
|
BUY |
$18.00
Est. +108%
|
$8.65 | $18.51 |
Precision Hit (±3%)
|
$8.56
-1.0%
|